ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Thorough Pre-Transplant Evaluation and Appropriate Case Selection Is the Mainstay for Better Survival in Recipients with Malignancy.

W. Yin.1,2

1Surgery, School of Medicine, Tzu Chi University, Hualien, Taiwan
2Surgery, Dalin Tzu Chi General Hospital, Chia-I, Taiwan.

Meeting: 2016 American Transplant Congress

Abstract number: B303

Keywords: Kidney transplantation, Liver transplantation, Malignancy, Post-transplant malignancy

Session Information

Date: Sunday, June 12, 2016

Session Name: Poster Session B: PTLD/Malignancies: All Topics

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Cohort Study of Solid Organ Transplant Recipients Who Develop Malignancy: Risk of Subsequent Malignancy on mTOR vs. Non-mTOR Regimens, A
  • Incidence of Post-Transplant Malignancy (PTM) After Pediatric Kidney Transplantation (PKTx).

Introduction

Malignancy has become one of the three major causes of death after transplantation in the past decade and is thus increasingly important in all organ transplant programs. Death from cardiovascular disease and infection are decreasing proper screening, prophylaxis, aggressive risk factor management, and interventional therapies. Cancer, on the other hand, is poorly screened both in recipient and donor to prevent post-transplant malignancy

Method

We review the cases of liver and kidney transplant patients taken care in Dalin Tzu Chi General hospital in the past twelve years. We reviewed the issues on cancer before transplant, any cancer transmission from the donor, cancer after transplantation, outcomes of transplant recipients with cancer, and the role of screening and therapy in reducing the impact of cancer in transplant recipients.

Results

1. There were 39 liver transplant and 44 kidney transplant patients with a total of 83 cases in this study. Sixteen cases (19.28 %) were associated with different types of malignancy.

A total of 16 cases (19.28%) died in this study.

2. Among the kidney transplant patients, a total of 5 cases had malignancy: one renal cell carcinoma (RCC), three Transitional cell carcinoma (TCC) and one colon cancer. Two TCC cases were de novo malignancy.

3. A case of TCC died of recurrence and no definite cancer was seen in the all 7 cases of LDKT.

4. Among the liver transplant patients, 5 cases of living donor liver transplant (LDLT) and 4 cases of deceased donor liver transplant (DDLT) patients were associated with malignancy.

5. No recurrence after follow up of 2 months to 7 years except a patient with an occult cecal cancer underwent laparoscopic radical right hemicolectomy two months after LDLT.

He died of distant metastases one year after transplant.

6. Four cases of malignancy in DDLT: two HCC, one prostate cancer, and one nasopharyngeal cancer (NPC) were noted.

7. Both of the HCC patients died of local and distant metastasis 3 months after DDLT from bone metastasis and about 3 years after transplantation respectively.

Conclusion

No significant difference in survival between cancer and non-cancer patients. We considered thorough preoperative screening for the possible small or occult cancer is fundamental to prevent poor prognosis.

CITATION INFORMATION: Yin W. Thorough Pre-Transplant Evaluation and Appropriate Case Selection Is the Mainstay for Better Survival in Recipients with Malignancy. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yin W. Thorough Pre-Transplant Evaluation and Appropriate Case Selection Is the Mainstay for Better Survival in Recipients with Malignancy. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/thorough-pre-transplant-evaluation-and-appropriate-case-selection-is-the-mainstay-for-better-survival-in-recipients-with-malignancy/. Accessed March 3, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.